Véronique Bourdeau

6.0k total citations · 2 hit papers
42 papers, 4.6k citations indexed

About

Véronique Bourdeau is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Véronique Bourdeau has authored 42 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Véronique Bourdeau's work include RNA modifications and cancer (8 papers), Cancer-related Molecular Pathways (8 papers) and Retinoids in leukemia and cellular processes (7 papers). Véronique Bourdeau is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related Molecular Pathways (8 papers) and Retinoids in leukemia and cellular processes (7 papers). Véronique Bourdeau collaborates with scholars based in Canada, United States and Belgium. Véronique Bourdeau's co-authors include Gerardo Ferbeyre, John H. White, Yoshihiko Nagai, Sylvie Mader, Luz E. Tavera-Mendoza, Tiantian Wang, Olga Moiseeva, Xavier Deschênes‐Simard, Frederick P. Nestel and Roberto Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Véronique Bourdeau

41 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression

2004 1.3k citations Tiantian Wang, Frederick P. Nestel et al. The Journal of Immunology profile →
Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation

2013 486 citations Olga Moiseeva, Xavier Deschênes‐Simard et al. Aging Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Véronique Bourdeau Canada	24	2.1k	1.2k	922	710	699	42	4.6k
Sylvie Mader Canada	33	3.1k 1.5×	1.4k 1.2×	360 0.4×	964 1.4×	390 0.6×	58	5.8k
Lucia Malaguarnera Italy	39	1.9k 0.9×	628 0.5×	634 0.7×	945 1.3×	188 0.3×	100	4.8k
Neus Prats Spain	35	1.6k 0.7×	955 0.8×	517 0.6×	609 0.9×	955 1.4×	86	5.0k
Peter Vadas Canada	39	2.2k 1.0×	279 0.2×	869 0.9×	1.0k 1.4×	428 0.6×	138	5.7k
Mamoru Satoh Japan	45	2.4k 1.1×	377 0.3×	643 0.7×	829 1.2×	801 1.1×	196	5.3k
Narayanan Parameswaran United States	36	2.7k 1.3×	271 0.2×	631 0.7×	837 1.2×	284 0.4×	99	4.7k
Karim C. El Kasmi United States	36	1.8k 0.9×	257 0.2×	697 0.8×	1.9k 2.6×	719 1.0×	67	5.8k
Lut Overbergh Belgium	35	1.1k 0.5×	1.7k 1.4×	599 0.6×	1.3k 1.8×	182 0.3×	104	4.8k
Eli C. Lewis Israel	31	1.6k 0.7×	348 0.3×	369 0.4×	1.1k 1.5×	688 1.0×	92	4.2k
Juan Zhang China	39	3.2k 1.5×	341 0.3×	675 0.7×	2.5k 3.5×	622 0.9×	211	6.5k

Countries citing papers authored by Véronique Bourdeau

Since Specialization

Citations

This map shows the geographic impact of Véronique Bourdeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Bourdeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Bourdeau more than expected).

Fields of papers citing papers by Véronique Bourdeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Bourdeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Bourdeau. The network helps show where Véronique Bourdeau may publish in the future.

Co-authorship network of co-authors of Véronique Bourdeau

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Bourdeau. A scholar is included among the top collaborators of Véronique Bourdeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Bourdeau. Véronique Bourdeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lopes‐Paciencia, Stéphane, Véronique Bourdeau, Marie‐Camille Rowell, et al.. (2024). A senescence restriction point acting on chromatin integrates oncogenic signals. Cell Reports. 43(4). 114044–114044. 4 indexed citations

Bourdeau, Véronique, et al.. (2024). Gaining Insight into Mitochondrial Targeting: AUTAC-Biguanide as an Anticancer Agent. Molecules. 29(16). 3773–3773. 2 indexed citations

Bourdeau, Véronique, et al.. (2024). Effects of Biguanide-PROTACs in Pancreatic Cancer Cells. Molecules. 29(22). 5329–5329.

Bourdeau, Véronique, Sebastian Igelmann, Marlene Oeffinger, et al.. (2024). Senescent Macrophages Release Inflammatory Cytokines and RNA-Loaded Extracellular Vesicles to Circumvent Fibroblast Senescence. Biomedicines. 12(5). 1089–1089. 7 indexed citations

Deschênes‐Simard, Xavier, Stéphane Lopes‐Paciencia, Benjamin Le Calvé, et al.. (2023). Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer. Cell Cycle. 22(19). 2172–2193. 8 indexed citations

Parisotto, Maxime, Paloma Kalegari, Sebastian Igelmann, et al.. (2022). The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells. Cancers. 14(22). 5597–5597. 11 indexed citations

Mascle, Xavier H., Laurent Cappadocia, Véronique Bourdeau, et al.. (2022). Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1. Nucleic Acids Research. 50(14). 8331–8348. 8 indexed citations

Lessard, Frédéric, Jordan Guillon, Sebastian Igelmann, et al.. (2021). Cellular senescence limits translational readthrough. Biology Open. 10(12). 2 indexed citations

Saint‐Germain, Emmanuelle, Lian Mignacca, Geneviève Huot, et al.. (2019). Phosphorylation of SOCS1 Inhibits the SOCS1–p53 Tumor Suppressor Axis. Cancer Research. 79(13). 3306–3319. 14 indexed citations

10.

Deschênes‐Simard, Xavier, Maxime Parisotto, Marie‐Camille Rowell, et al.. (2019). Circumventing senescence is associated with stem cell properties and metformin sensitivity. Aging Cell. 18(2). e12889–e12889. 34 indexed citations

11.

Lessard, Frédéric, Sebastian Igelmann, Christian Trahan, et al.. (2018). Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway. Nature Cell Biology. 20(7). 789–799. 111 indexed citations

12.

Vernier, Mathieu, Lian Mignacca, Frédéric Lessard, et al.. (2016). A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence. Cancer Research. 76(11). 3252–3264. 48 indexed citations

13.

Mukhopadhyay, Utpal K., Leda Raptis, Andrew W. Craig, et al.. (2016). STAT5A is regulated by DNA damage via the tumor suppressor p53. Cytokine. 82. 70–79. 8 indexed citations

14.

Huot, Geneviève, Mathieu Vernier, Véronique Bourdeau, et al.. (2014). CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis. Molecular Biology of the Cell. 25(5). 554–565. 29 indexed citations

15.

Moiseeva, Olga, Xavier Deschênes‐Simard, Sebastian Igelmann, et al.. (2013). Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation. Aging Cell. 12(3). 489–498. 486 indexed citations breakdown →

16.

Deschênes‐Simard, Xavier, Marie‐France Gaumont‐Leclerc, Véronique Bourdeau, et al.. (2013). Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes & Development. 27(8). 900–915. 147 indexed citations

17.

Moiseeva, Olga, Véronique Bourdeau, Antoine E. Roux, Xavier Deschênes‐Simard, & Gerardo Ferbeyre. (2009). Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence. Molecular and Cellular Biology. 29(16). 4495–4507. 298 indexed citations

18.

Palijan, Ana, Isabelle Fernandes, Mark Verway, et al.. (2009). Ligand-dependent Corepressor LCoR Is an Attenuator of Progesterone-regulated Gene Expression. Journal of Biological Chemistry. 284(44). 30275–30287. 32 indexed citations

19.

Wang, Tiantian, Frederick P. Nestel, Véronique Bourdeau, et al.. (2004). Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression. The Journal of Immunology. 173(10). 6490–6490. 86 indexed citations

20.

Bourdeau, Véronique, Julie Deschênes, Raphaël Métivier, et al.. (2004). Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse. Molecular Endocrinology. 18(6). 1411–1427. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact